1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. ECO-FRIENDLY NATURE OF NON-PVC IV BAGS
3.1.2. PREVALENCE OF CANCER IMPACTING PARENTERAL NUTRITION
3.1.3. PREVAILING NATALITY AND BIRTH RATES
3.2. KEY RESTRAINTS
3.2.1. STRINGENT REGULATIONS ASSOCIATED WITH THE USAGE OF PHTHALATES AND THE PRODUCTION PROCESS OF IV SOLUTIONS
3.2.2. HIGH COST OF NON-PVC IV BAGS

4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON NON-PVC IV BAGS MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRY
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE

5. MARKET BY PRODUCT
5.1. SINGLE CHAMBER
5.2. MULTI-CHAMBER

6. MARKET BY MATERIAL
6.1. ETHYLENE-VINYL ACETATE
6.2. POLYPROPYLENE
6.3. COPOLYESTER ETHER
6.4. OTHER MATERIALS

7. MARKET BY CONTENT TYPE
7.1. LIQUID MIXTURE
7.2. FROZEN MIXTURE

8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. KEY GROWTH ENABLERS
8.1.3. KEY CHALLENGES
8.1.4. KEY PLAYERS
8.1.5. COUNTRY ANALYSIS
8.1.5.1. UNITED STATES
8.1.5.2. CANADA

9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ANGIPLAST PVT LTD
9.2.2. B BRAUN MELSUNGEN AG
9.2.3. BAXTER INTERNATIONAL INC
9.2.4. FRESENIUS KABI
9.2.5. HUAREN PHARMACEUTICAL
9.2.6. ICU MEDICAL
9.2.7. JW LIFE SCIENCE
9.2.8. KRATON CORPORATION
9.2.9. MEDIPHARMAPLAN
9.2.10. OTSUKA
9.2.11. PFIZER INC
9.2.12. POLYCINE GMBH
9.2.13. RENOLIT
9.2.14. SEALED AIR
9.2.15. SHANGHAI XIN GEN ECO-TECHNOLOGIES